OrganiGram reports FY2024 net revenue of CAD 159.8 million, up 17.6 percent
OrganiGram Global Inc. reported a 17.6% increase in net revenue to CAD 159.8 million for FY2024, with a 37% adjusted gross margin and CAD 5.9 million in adjusted EBITDA for Q4. The company also achieved CAD 8.9 million in cash flow from operations in Q4. Post-acquisition of Motif Labs, OrganiGram became Canada's largest cannabis company by market share. This information is AI-generated and not financial advice.
OrganiGram Global Inc. reported net revenue of CAD 159.8 million for fiscal year 2024, reflecting a 17.6 percent increase in recreational shipped sales compared to the previous year. For the fourth quarter of fiscal 2024, the company reported an adjusted gross margin of 37 percent and adjusted EBITDA of CAD 5.9 million, representing 13 percent of net revenue. Cash flow from operations in the fourth quarter was CAD 8.9 million. Following the acquisition of Motif Labs after the year-end, OrganiGram Global Inc. became Canada’s largest cannabis company by market share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrganiGram Global Inc. published the original content used to generate this news brief on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
